535 related articles for article (PubMed ID: 35923762)
1. Inflammatory pathways in COVID-19: Mechanism and therapeutic interventions.
Jiang Y; Zhao T; Zhou X; Xiang Y; Gutierrez-Castrellon P; Ma X
MedComm (2020); 2022 Sep; 3(3):e154. PubMed ID: 35923762
[TBL] [Abstract][Full Text] [Related]
2. The signal pathways and treatment of cytokine storm in COVID-19.
Yang L; Xie X; Tu Z; Fu J; Xu D; Zhou Y
Signal Transduct Target Ther; 2021 Jul; 6(1):255. PubMed ID: 34234112
[TBL] [Abstract][Full Text] [Related]
3. Diverse Immunological Factors Influencing Pathogenesis in Patients with COVID-19: A Review on Viral Dissemination, Immunotherapeutic Options to Counter Cytokine Storm and Inflammatory Responses.
Rabaan AA; Al-Ahmed SH; Garout MA; Al-Qaaneh AM; Sule AA; Tirupathi R; Mutair AA; Alhumaid S; Hasan A; Dhawan M; Tiwari R; Sharun K; Mohapatra RK; Mitra S; Emran TB; Bilal M; Singh R; Alyami SA; Moni MA; Dhama K
Pathogens; 2021 May; 10(5):. PubMed ID: 34066983
[TBL] [Abstract][Full Text] [Related]
4. Surviving the Storm: Cytokine Biosignature in SARS-CoV-2 Severity Prediction.
Ahmad R; Haque M
Vaccines (Basel); 2022 Apr; 10(4):. PubMed ID: 35455363
[TBL] [Abstract][Full Text] [Related]
5. Role of Inflammatory Cytokines in COVID-19 Patients: A Review on Molecular Mechanisms, Immune Functions, Immunopathology and Immunomodulatory Drugs to Counter Cytokine Storm.
Rabaan AA; Al-Ahmed SH; Muhammad J; Khan A; Sule AA; Tirupathi R; Mutair AA; Alhumaid S; Al-Omari A; Dhawan M; Tiwari R; Sharun K; Mohapatra RK; Mitra S; Bilal M; Alyami SA; Emran TB; Moni MA; Dhama K
Vaccines (Basel); 2021 Apr; 9(5):. PubMed ID: 33946736
[TBL] [Abstract][Full Text] [Related]
6. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
[TBL] [Abstract][Full Text] [Related]
7. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
[TBL] [Abstract][Full Text] [Related]
8. Storm at the Time of Corona: A Glimpse at the Current Understanding and Therapeutic Opportunities of the SARS-CoV-2 Cytokine Storm.
Torabi-Rahvar M; Rezaei N
Curr Pharm Des; 2021; 27(13):1549-1552. PubMed ID: 33238863
[TBL] [Abstract][Full Text] [Related]
9. Dysregulated Innate Immune and Inflammatory Responses in SARS-CoV-2 Infection and COVID-19 Severity.
Ghosh P; Nagaraja S; Basavaraju S; Kesavardhana S
Crit Rev Immunol; 2021; 41(3):43-56. PubMed ID: 35378010
[TBL] [Abstract][Full Text] [Related]
10. Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19?
Panigrahy D; Gilligan MM; Huang S; Gartung A; Cortés-Puch I; Sime PJ; Phipps RP; Serhan CN; Hammock BD
Cancer Metastasis Rev; 2020 Jun; 39(2):337-340. PubMed ID: 32385712
[TBL] [Abstract][Full Text] [Related]
11. COVID-19: Inflammatory Profile.
Wang Y; Perlman S
Annu Rev Med; 2022 Jan; 73():65-80. PubMed ID: 34437814
[TBL] [Abstract][Full Text] [Related]
12. Hypoxemia and Cytokine Storm in COVID-19: Clinical Implications.
Machado C; González-Quevedo A
MEDICC Rev; 2021; 23(3-4):54-59. PubMed ID: 34516537
[TBL] [Abstract][Full Text] [Related]
13. Novel Coronavirus Disease 2019 (COVID-19) and Cytokine Storms for More Effective Treatments from an Inflammatory Pathophysiology.
Yokota S; Miyamae T; Kuroiwa Y; Nishioka K
J Clin Med; 2021 Feb; 10(4):. PubMed ID: 33671159
[TBL] [Abstract][Full Text] [Related]
14. Molecular Pathogenesis, Immunopathogenesis and Novel Therapeutic Strategy Against COVID-19.
Chatterjee SK; Saha S; Munoz MNM
Front Mol Biosci; 2020; 7():196. PubMed ID: 32850977
[TBL] [Abstract][Full Text] [Related]
15. Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19.
Azkur AK; Akdis M; Azkur D; Sokolowska M; van de Veen W; Brüggen MC; O'Mahony L; Gao Y; Nadeau K; Akdis CA
Allergy; 2020 Jul; 75(7):1564-1581. PubMed ID: 32396996
[TBL] [Abstract][Full Text] [Related]
16. Potential therapeutic approaches for targeted inhibition of inflammatory cytokines following COVID-19 infection-induced cytokine storm.
Morgulchik N; Athanasopoulou F; Chu E; Lam Y; Kamaly N
Interface Focus; 2022 Feb; 12(1):20210006. PubMed ID: 34956607
[TBL] [Abstract][Full Text] [Related]
17. Nutraceutical Targeting of Inflammation-Modulating microRNAs in Severe Forms of COVID-19: A Novel Approach to Prevent the Cytokine Storm.
Desjarlais M; Wirth M; Lahaie I; Ruknudin P; Hardy P; Rivard A; Chemtob S
Front Pharmacol; 2020; 11():602999. PubMed ID: 33362557
[TBL] [Abstract][Full Text] [Related]
18. Cytokine storm in COVID-19: from viral infection to immune responses, diagnosis and therapy.
Jiang Y; Rubin L; Peng T; Liu L; Xing X; Lazarovici P; Zheng W
Int J Biol Sci; 2022; 18(2):459-472. PubMed ID: 35002503
[TBL] [Abstract][Full Text] [Related]
19. Potential Implications of Black Seed and its Principal Constituent Thymoquinone in the Treatment of COVID-19 Patients.
Khan MA; Younus H
Curr Pharm Biotechnol; 2021; 22(10):1315-1324. PubMed ID: 33176642
[TBL] [Abstract][Full Text] [Related]
20. Immunopathology and Immunopathogenesis of COVID-19, what we know and what we should learn.
Shahgolzari M; Yavari A; Arjeini Y; Miri SM; Darabi A; Mozaffari Nejad AS; Keshavarz M
Gene Rep; 2021 Dec; 25():101417. PubMed ID: 34778602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
